Soundwatch Capital LLC Acquires Shares of 770 Johnson & Johnson $JNJ

Soundwatch Capital LLC bought a new position in shares of Johnson & Johnson (NYSE:JNJ) in the second quarter, Holdings Channel reports. The fund bought 770 shares of the company’s stock, valued at approximately $118,000.

Other institutional investors and hedge funds have also modified their holdings of the company. GFG Capital LLC bought a new position in shares of Johnson & Johnson during the second quarter worth approximately $35,000. Stone House Investment Management LLC bought a new position in shares of Johnson & Johnson in the 1st quarter valued at $47,000. 1248 Management LLC acquired a new position in Johnson & Johnson during the first quarter worth about $48,000. Harvest Fund Management Co. Ltd bought a new position in Johnson & Johnson in the 1st quarter valued at approximately $52,000. Finally, Pandora Wealth Inc. bought a new position in shares of Johnson & Johnson in the 1st quarter valued at $65,000. 69.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Johnson & Johnson

In other news, EVP Jennifer L. Taubert sold 56,471 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $177.81, for a total value of $10,041,108.51. Following the completion of the sale, the executive vice president owned 178,013 shares in the company, valued at $31,652,491.53. This represents a 24.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.16% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Daiwa Capital Markets upgraded Johnson & Johnson from a “neutral” rating to an “outperform” rating and set a $203.00 price target on the stock in a report on Monday, October 20th. Royal Bank Of Canada reiterated an “outperform” rating and set a $209.00 price target on shares of Johnson & Johnson in a report on Friday, October 10th. Stifel Nicolaus raised their price objective on shares of Johnson & Johnson from $165.00 to $190.00 and gave the stock a “hold” rating in a research report on Wednesday, October 15th. Sanford C. Bernstein increased their price objective on shares of Johnson & Johnson from $172.00 to $193.00 and gave the stock a “market perform” rating in a research report on Monday, October 6th. Finally, Morgan Stanley set a $190.00 target price on Johnson & Johnson in a research report on Wednesday, October 15th. Four research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $201.05.

Johnson & Johnson Trading Up 0.4%

JNJ opened at $203.88 on Friday. The firm has a market capitalization of $491.21 billion, a PE ratio of 19.68, a P/E/G ratio of 2.19 and a beta of 0.38. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.80. Johnson & Johnson has a fifty-two week low of $140.68 and a fifty-two week high of $206.94. The company’s 50-day moving average is $188.25 and its 200 day moving average is $171.67.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 EPS for the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%.The firm had revenue of $24.02 billion during the quarter. As a group, research analysts predict that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 25th will be paid a dividend of $1.30 per share. The ex-dividend date is Tuesday, November 25th. This represents a $5.20 annualized dividend and a yield of 2.6%. Johnson & Johnson’s dividend payout ratio (DPR) is 50.19%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.